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The following series of  observations suggests that  plasma  from blood 
in  the  peripheral  vessels  of  hypertensive dogs  and  patients  contains  a 
pressor substance, probably angiotonin.  The evidence, which has elimi- 
nated the nervous and endocrine systems as more than regulators of the 
somatic substrate on which a primary genetic agent acts to produce hyper- 
tension, has  been reviewed (1).  In  experimental hypertension, whether 
produced by constricting the renal artery (Goldblatt, Lynch, Hanzal, and 
Summerville (2))  or by compressing the renal parenchyma by the fibro- 
collagenous scar resulting from cellophane or silk perinephritis (Page (3)), 
the possibility must be entertained that angiotonin, derived from renin, 
is the genetic agent.  There are five chief reasons for supposing so.  (a) 
When infused into animals, angiotonin or renin reproduces the intra-renal 
hemodynamic changes, namely, relative increase in intraglomerular pres- 
sure and decrease in peritubular blood flow  (Corcoran and Page  (4))  as 
found in patients with  essential hypertension (Smith,  Goldring,  Chasis, 
and  Ranges  (5)).  (b)  They  elevate  arterial  pressure  without  causing 
fall  in  skin  temperature  (Landis,  Montgomery, and  Sparkman  (6)  and 
Corcoran and Page (7)).  (c) Renin appears in greatly increased amounts 
in the renal venous blood of dogs with experimental hypertension (Page 
(8))  and  after  reducing the pulse  pressure  in  isolated perfused kidneys 
(Kohlstaedt and Page (9)).  (d) It may be increased in amount in the renal 
parenchyma of hypertensive rats (Harrison, Blalock, Mason, and Williams 
(10)  and  Prinzmetal,  Friedman,  and  Abramson  (19)).  (e)  Lastly,  the 
pressor  action  of  both  renin  and  angiotonin is  enhanced by  producing 
chronic hypertension in dogs or by bilateral nephrectomy. 
Extracts  of kidney containing renin were first prepared by Tigerstedt 
and Bergmann (11).  Purification of similar extracts led to the observation 
that renin itself is not a  pressor substance  (Helmer and Page  (12)),  but 
that it only elicits vasoconstriction when allowed to interact with a pseudo- 
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globulin fraction of blood termed renin-activator by Kohlstaedt, Helmer, 
and Page (13, 14).  The product of this reaction was crystallized and named 
angiotonin  (15,  16).  All  the  evidence accumulated points  to  the  belief 
that angiotonin is the effector substance and that renin is a vaso-inactive, 
mother substance. 
The  stimulus  to  liberation  of renin  from isolated  perfused kidneys is 
reduction of pulse pressure and possibly the same is true in intact animals 
(9),  for  renal  venous blood  of hypertensive animals  contains  abundant 
renin in  contrast to  blood from normal kidneys which contains little  or 
none (8). 
Renin is demonstrated by addition of renin-activator to plasma contain- 
ing it.  The  addition  of renin-activator is necessary because the  supply 
of activator  in  the blood  stream is  limited  (1)  and  addition  of unusual 
amounts of renin  quickly exhausts it  (in part  the phenomenon of renin 
"tachyphylaxis"). 
It appears that the renin which is liberated from the kidneys reacts with 
the renin-activator of the blood to produce angiotonin and this accounts 
for the fact that the amount of renin in the blood rapidly diminishes after 
leaving  the kidneys and that  there is little  more of it in  the peripheral 
blood of hypertensive animals than in that of normal ones (8), but by the 
same token the amount of angiotonin should be increased.  The purpose 
of this investigation was to ascertain whether this is true. 
Since  bilateral  nephrectomy  greatly  enhances  the  pressor  action  of 
angiotonin both  in  intact  animals  and in  isolated rabbits'  ears perfused 
with angiotonin and plasma from nephrectomized animals, because of lack 
of inhibitor  (1,  17)  it  seemed desirable to  employ the latter preparation 
without  addition  of  angiotonin.  If  angiotonin  were  contained  in  the 
peripheral blood of hypertensive animals and patients with essential hyper- 
tension, the addition of their plasma should cause marked vasoconstriction, 
whereas plasma from normal dogs or persons should not. 
Methods 
The method employed for demonstration of pressor substance has been described 
(1, 17).  It consists of perfusing an isolated rabbit's  ear with blood or Ringer-Locke's 
solution  using pulsatile  pressure.  Control injections  into  Ringer-Locke's solution 
perfusing the ear were always given to demonstrate that the plasma alone had little or 
no vasoconstrictor properties.  Blood was removed from bilaterally nephrectomized 
dogs 2 days after the operation,  1 defibrinated, diluted 1 : 1 with Ringer's solution, and 
employed as circulating medium. 
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The number of drops flowing from the ear are recorded and serve as an index of both 
the length and intensity of vasoconstriction. 
The blood to be tested was drawn from either the femoral or radial arteries or from 
the femoral, renal, or antecubital veins, heparinized, centrifuged, and the plasma drawn 
off for use.  For the test, 0.4 cc. of plasma was injected.  Patients with essential  and 
malignant  hypertension  from  the  Lilly  Clinic  were  donors.  Pronounced,  chronic 
hypertension was produced in dogs by the silk  2 perinephritis method (3), or by con- 
stricting the renal artery (Goldblatt, Lynch, Hanzal, and SummerviUe  (2)), and their 
blood was employed for testing.  When blood from the renal vein was desired,  the kid- 
neys were explanted by the method of Page and Corcoran (18), and, after healing had 
occurred, the renal artery was  constricted by a Goldblatt clamp to elicit hypertension. 
RESULTS 
When Ringer's solution is employed  to perfuse the  rabbit's  ear  and 
plasma from  either normal  or hypertensive subjects is added to it, usually 
no vasoconstriction  results, or at most only  an insignificant  amount.  Even 
if blood  from  normal dogs  is employed,  plasma from  hypertensives causes 
only slight constriction; but,  if instead of Ringer's solution or normal 
blood, blood taken 24 or more hours from a bilaterally nephrectomized 
dog is used for perfusion, then addition of only small amounts (0.4 cc.) 
of plasma from  both hypertensive  patients and dogs cause marked constric- 
tion and, contrariwise, plasma from normal man and dogs causes none 
(Table I). 
Plasma from the renal vein blood of normal animals or from the femoral 
vessels  produces  an  insignificant  amount  of  vasoconstriction  (Table  IV). 
But  plasma  from  the  renal  vein  of  hypertensive  animals  elicits  marked 
vasoconstriction though usually somewhat less than that from the femoral 
vessels. 
The opportunity was presented to examine the renal vein plasma of one 
patient with hypertension.  Blood was collected from the renal vein while 
the  patient  was  under  ether  anesthesia  undergoing  a  sympathectomy. 
This was compared with blood drawn simultaneously from the antecubital 
vein.  The  plasma  from  the  antecubital  vein  caused  reduction  of  flow 
of 54 per cent in the rabbit's ear lasting 9 minutes, and the renal vein blood 
reduced the flow 45  per cent for 8  minutes.  The arterial pressure before 
anesthesia  was  210/120  mm.  Hg,  and  while  the  blood  was  being  drawn 
128/80  mm.  Hg.  27  days after operation when  the  arterial pressure  was 
reduced  to  170/110  mm.  Hg  the  plasma  caused  reduction  of  flow  of  48 
per cent for 4  minutes. 
2 Silk crepe has proved very satisfactory for the production of perinephritis.  Nylon 
is reasonably satisfactory, but not as suitable as crepe silk. TAJ~LJ~  1 
Vasoconstrictor  Action of Plasma from Hypertensive Patients and Dogs 
When Perfused through  a Rabbit's Ear 
[Amount]Arterial[ Initial  Duration I  of reduc-] Reduc-  Perfuslng medium  Origin of plasma  B.P.  of  or  now  tion of  tion of 
plasma  venous  tm~.n  r.  flow  flow 
Ear 
Ringer's  Normal dog 
Hypertensive dog 8-08 
Angiotonin 
Angiotonin 0.2 cc. plus nor- 
mal plasma 0.2 cc. 
Angiotonin  0.2  cc. plus hy- 
pertensive plasma 0.2 cc. 
Ear 
mm. Hg 
116 
CO° 
0.6 
0.6 
0.5 
drops 
V  IO0 
V  IO0 
96 
92 
94 
mln. 
0 
0 
3~ 
1 
p~r  c#~ 
0 
0 
70 
35 
50 
Nephrectomized 
dog's blood 
Normal dog 
Normal dog 
Hypertensive dog 8-08 
Hypertensive dog 8-08 
Normal dog 
0.5  V 
0.5  V 
0.5  A 
0.5  A 
0.5  V 
10  0 
10  0 
14  15 
8  10 
7  0 
0 
0 
77 
69 
0 
Ear 3 
Nephrectomized 
dog's blood 
Normal dog 1-26  ! 
Normal dog 
Hypertensive dog 7-90 
Hypertensive dog 7-90 
Malignant hypertensive  pa-  242/148 
fient 
Malignant hypertensive  pa- 
tient 
Normal dog 1-32 
Hypertensive dog 7-90 
Hypertensive dog 7-90 
0.4 
0.4 
0.4 
0.4 
0.4 
0.4 
0.4 
0.4 
0.4 
A 
V 
V 
A 
V 
A 
A 
V 
A 
12  0 
10  0 
10  11 
8  7 
6  4 
6  5 
6  0 
6  9 
5  5 
0 
0 
86 
89 
42 
60 
0 
73 
60 
Ear 4 
Nephrectomized 
dog's blood 
Normal man 
Malignant  hypertensive  man 
Normal man 
Malignant  hypertensive 
woman 
Malignant hypertensive 
woman 
Malignant hypertensive 
woman 
Normal man 
Normal man 
Malignant hypertensive 
woman 
Malignant  hypertensive  man 
124/84  I 
250/1481 
118/881 
230/1461 
130/861 
230/1461 
250/1481 
0.4  V 
0.4  A 
0.4  A 
0.4  A 
0.4  V 
0.4  A 
0.4  V 
0.4  A 
0.4  A 
0.4  V 
0 
10 
0 
12 
14 
16 
0 
0 
15 
12 
0 
42 
0 
52 
58 
64 
0 
0 
56 
46 
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We have been unable to detect any consistent difference in vasoconstric- 
tor  properties  between  the  femoral  arterial  and  venous  blood  either  of 
hypertensive dogs or man  (Tables II and  III). 
As a  control one animal had one kidney removed and renal artery of the 
other  almost closed by a  Goldblatt  clamp.  Pronounced  uremia  occurred 
TABLE  II 
Summary  of Results of Examination  of Blood  from Normal  and  Hypertensive Patients. 
Rabbits' Ears Perfused with Blood from Nephrectomized Dogs and 
Plasma  (0.4 Cc.) Injected 
Patient 
Normal 
Normal 
Normal 
Pellagra 
Pellagra 
Malignant hypertension 
Malignant hypertension 
Malignant hypertension 
Malignant hypertension 
Malignant hypertension 
Malignant hypertension 
Essential hypertension with dien- 
cephalic syndrome 
Essential hypertension 
Essential hypertension 
Chronic nephritis with hyperten- 
sion 
Essential hypertension 
B.P. 
ram. H~ 
126/70 
130/78 
120/84 
80•58 
98/72 
242/148 
228/148 
228/144 
210/158 
192/132 
184/124 
220/126 
150/96 
196/130 
196/110 
180/100 
Normal man 
Arterial  blood  Venous blood 
Initial 
flow  per 
/IllS. 
drops 
5 
3 
3 
6 
Duration 
of reduc- 
tion  of 
flow 
rain. 
0 
0 
0 
0 
Rcduc-  Initial 
tion of  flow per 
flow  rain. 
per ~n~  drops 
0  6 
0  3 
0  4 
0  7 
--  30 
Hyper  tenmve man 
Duration 
of reduc- 
tion of 
flow 
~it;. 
0 
0 
0 
0 
2 
Reduc- 
tion of 
flow 
per  ¢e~ 
0 
0 
0 
0 
38 
5 
7 
5 
10 
12 
16 
15 
8 
4 
60 
42 
52 
64 
56 
64 
48 
3  50 
5  59 
4 
4 
7 
30 
6  4 
3  12 
14 
6 
4 
42 
46 
58 
61 
50 
3  44 
5  53 
4  6O 
4½  52 
without  significant  rise  of  arterial  pressure.  6  days  after  operation  the 
mean  arterial  pressure  was  130  mm.  Hg  and  the  urea nitrogen  207  mg. 
per  100  cc.  of blood.  A  sample  of plasma from this  dog  when  perfused 
caused  a  reduction  of flow of 16 per  cent  lasting  only  1  minute,  which  is 
not greater than plasma from a  normal animal. 
Plasma from patients suffering from either malignant or essential hyper- 
tension causes severe vasoconstriction.  Even in those patients with essential 306  VASOCONSTRICTOR  ACTION  OF  PLASMA 
hypertension in whom the nervous element is predominant--the so called 
hypertensive diencephalic syndrome (20)--the plasma caused vasoconstric- 
tion.  The plasma of one patient with typical chronic Bright's disease and 
hypertension exhibited enhanced vasoconstrictor action  suggesting  simi- 
larity of genesis with essential hypertension. 
TABLE  III 
Comparison  of Femoral Arterial and Venous Plasma from Normal Dogs and Dogs Made 
Hypertensive  by Silk Perinephritis 
Normal dogs 
Dog No. 
nnn.  flow 
drops  rain.  per cent  drops 
8-28  10  0  0  10 
8-35  12  0  0  10 
8-35  6  0  0  -- 
8-35  10  1  21  8 
8-59  4  1  25  4 
8-59  3  1  34  4 
8-35  36  0  0  4 
8-69  34  1A  24 
Arterial blood  Venous blood 
Initial  Duration  Initial  flow per  of reduc-  Reduction  flow  Duration of 
tion of  of flow  per rain.  reduction  Reduction of flow 
of flow 
mln. 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
per cent 
Hypertensive dogs 
8-08  14 
7-90  8 
7-90  5 
7-52  10 
7-81  4 
4-18  3 
6-16  32 
4-18  5 
15 
7 
5 
6 
2O 
5~ 
7 
77 
89 
60 
59 
30 
100 
57 
63 
10  11  86 
6  9  73 
8  6  64 Blood urea nitrogen 
=  54 mg. 
Blood pressure reduced  from  182  to  100  mm. 
Hg by  extract  of  kidney.  Blood  urea  nitro- 
gen -- 94 mg. per 100 cc. 
It  will also  be  observed  that  the  plasma  from  hypertensives  causes 
greater vasoconstriction than does normal plasma when mixed with angio- 
tonin and injected, confirming earlier work (14). 
DISCUSSION 
Plasma  from patients  with essential hypertension or  chronic Bright's 
disease with hypertension causes marked vasoconstriction when perfused IRVINE H. PAGE  307 
in small amounts through a rabbit's ear irrigated with blood from a nephrec- 
tomized dog.  The same type of vasoconstriction occurs when plasma of 
dogs made hypertensive either by perinephritis or constricting the renal 
artery is  employed.  The most marked vasoconstriction is produced by 
TABLE  IV 
Comparison of Renal  Venous  Plasma  and  Femoral Arterial  and  Venous Plasma When 
Perfused with Blood from a Nephrectomized Dog 
Dog  Blood sample  No, 
5-52  Renal venous 
Femoral venous 
4-97  Renal venous 
Femoral venous 
4-97  Renal venous 
Femoral venous 
5-96  Renal venous 
5-96  Renal venous 
Femoral arterial 
8-59  Femoral arterial 
2-28  Renal venous 
Femoral arterial 
2-28  Renal venous 
Femoral arterial 
2-28  Renal venous 
Femoral venous 
Normal explanted kidney 
Normal explanted kidney 
Normal explanted kidne~ 
Normal explanted kidney 
Normal explanted kidney 
Normal dog 
Renal artery clamped 
Renal artery clamped 
Renal artery clamped 
blood drawn from the peripheral vessels and somewhat less by that from 
the renal veins. 
It is our belief that these results are best explained on the basis of the 
renin-angiotonin vasopressor system.  Renin is liberated from the kidneys 
into the renal veins as the result, for instance, of reduction of pulse pressure 
(9).  It reacts with the renin-activator in the blood causing it to diminish 
in amount steadily after leaving the kidneys (8).  On reaching the periph- 
ery, little appears to remain in  the blood.  The product of the reaction 308  VASOCONSTRICTOR  ACTION OF PLASMA 
between renin and renin-activator, at least ~n vitro, is the water-soluble, 
dialyzable  pressor  substance  called  angiotonin  (15,  16).  If  a  similar 
reaction occurs, in vivo, the renin should be replaced by angiotonin. 
It  has  been  shown that  angiotonin requires the presence of a  second 
substance, angiotonin-activator, to exert its full vasoconstrictor action in 
organs perfused with  Ringer's solution (17).  This activator is  supplied 
abundantly by  normal blood.  But  normal blood  appears  to  contain  a 
substance having its  origin in  the kidneys which inhibits the  action  of 
angiotonin  (1,  17).  Hence  to  elicit  maximum  vasoconstriction  from 
angiotonin in a perfused organ, the perfusing fluid would best be blood from 
a nephrectomized animal.  For these reasons the rabbit's ear perfused with 
blood from dogs with both kidneys removed was  used  as  a  method to 
demonstrate  the  presence  of  angiotonin.  The  marked  vasoconstriction 
elicited by plasma from hypertensives under these circumstances suggests 
strongly that such blood contains angiotonin. 
A means would, therefore, seem to be at hand for differentiating hyper- 
tension of renal from that of other origins.  Among the patients examined, 
plasma from typical cases of essential hypertension, essential hypertension 
with  the  diencephalic  syndrome,  malignant  hypertension,  and  Bright's 
disease with hypertension elicited vasoconstriction, whereas that from the 
group of normotensive patients did not.  Similar results were obtained in 
comparing experimentally hypertensive and normal dogs. 
The relative amounts of renin and angiotonin in the blood from the renal 
vein must depend  on a  variety of  circumstances.  Blood  removed from 
the renal vein of an unanesthetized hypertensive dog appears to contain 
large amounts of renin  (8),  while blood from the renal vein of a  patient 
under  ether  anesthesia  contained  relatively  more  angiotonin.  More 
extensive investigation of this problem is required as it might furnish the 
clue to the problem of which kidney to remove in so called unilateral renal 
disease.  It would seem reasonable to remove the kidney which is liberating 
renin and angiotonin. 
These observations and those demonstrating that the renin- and angio- 
tonin-activator content of the blood is increased or the inhibitor content 
decreased, or both (8,  14), add cogent evidence, we believe, to the identity 
of the chemical mediator in all of these clinical types of hypertension and 
to the belief that the mediator is angiotonin or one of its derivatives. 
It is difficult at present to know how to fit our observation with those of 
Houssay  and  his  collaborators.  Fasciolo,  Houssay,  and  Taquini  (21) 
showed that grafting a markedly ischemic kidney onto the neck vessels of a 
dog produced a rise of blood pressure.  Others have confirmed this observa- IRVII~  I-I. PAGIE  309 
tion.  Their observation may be  taken as indicating the liberation  of a 
substance from the ischemic kidney which in the presence of blood causes 
a rise in arterial pressure.  The observation of Houssay and Taquini (22) 
that plasma of citrated venous blood from an ischemic kidney produced 
vasoconstriction in a  perfused toad, whereas normal blood did not, needs 
further investigation as Mason and Rozzell (23)  were unable to verify it. 
Braun-Menendez,  Fasciolo,  Leloir,  and  Mufioz  (24)  noted greater  than 
normal pressor action of extracts prepared from renal vein blood of ischemic 
kidneys, and Braun-Menendez and Fasciolo (25) found serum (10 to 20 cc.) 
prepared from blood of a perfused ischemic kidney to cause a greater rise in 
blood pressure of anesthetized dogs than serum of blood from normal kid- 
neys.  It is not known why such small amounts of serum cause rise in 
arterial pressure when large transfusions of blood from hypertensive animals 
appear to cause comparatively little pressor action.  Whether the extracts 
prepared from renal vein blood contain angiotonin remains to be  deter- 
mined.  These important observations add weight to the belief that pressor 
substances are in fact liberated by the kidneys. 
SUMMARY 
I.  Plasma from the renal vein, femoral artery or vein of normal dogs and 
plasma from  the  femoral  artery,  femoral and  antecubital  veins  of man 
cause little or no vasoconstriction when added in small amounts to  blood 
from a  bilaterally nephrectomized dog used  as  perfusing medium in  an 
isolated rabbit's  ear. 
2.  Plasma  from  the  femoral  vessels  and  antecubital  vein  of  patients 
with essential hypertension, malignant hypertension, and chronic nephritic 
hypertension  causes  marked  vasoconstriction  under  the  same  circum- 
stances.  The plasma  of dogs made hypertensive either by  constriction 
of the parenchyma by the scar of silk perinephritis or by constriction of the 
renal artery by a clamp also causes pronounced vasoconstriction. 
3.  Plasma from the renal vein of normal dogs produces little or no vaso- 
constriction,  but  that  of  hypertensive dogs  elicits  vasoconstriction but 
usually not so marked as that elicited by plasma collected from peripheral 
vessels.  A sample of renal venous plasma from one hypertensive patient 
caused severe vasoconstriction, not quite so intense as that produced by 
the peripheral vein plasma. 
4.  Since renin is liberated into the renal vein in large amounts in hyper- 
tensive dogs and reacts  with renin-activator to  produce angiotonin and 
since the conditions of the experiment are such as to enhance greatly the 
sensitivity of the ear preparation to angiotonin, it is believed that the vaso- 310  VASOCONSTRICTOR ACTION OF PLASMA 
constriction  is  the  result  of  the  presence of  angiotonin  in the  peripheral 
blood. 
5.  Since vasoconstriction occurs under the same experimental conditions 
with plasma from both hypertensive patients  and  dogs, this is considered 
cogent evidence in favor of the view that the chemical mediator of both is 
similar  and  is possibly angiotonin. 
6.  A  method  is  presented  which  is  believed  will  distinguish  between 
plasma  from  patients  with  normal  blood  pressure  and  that  from  those 
with hypertension, and  between plasma  from normal  dogs and  that  from 
dogs with experimental renal hypertension. 
We wish to thank Mrs. Marian Norman and Mr. Roland Parker  for technical assist- 
ance. 
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